NEWS
ZURICH (Reuters) – Novartis on Monday announced the appointment of Gilbert Ghostine as chairman-designate of Sandoz, the generics unit Novartis wants to spin off later this year.
Ghostine has been CEO of Geneva-based Firmenich, the world’s largest privately owned perfume and taste company, since 2014.
He will become the chairman of the new board at Sandoz, which is to be formed after its spin-off from Novartis in the second half of 2023, subject to final Novartis Board of Directors and shareholder approvals.
(Reporting by John Revill; Editing by Paul Carrel)
-
-
BUSINESS4 days ago
Building a Diverse and Inclusive Team in Your Startup
-
-
-
FINANCE4 days ago
Changelly launches Probably Serious Quiz introducing 0% fee swaps of USDt on TON and Toncoin
-
-
-
NEWS3 days ago
Global equity market-neutral hedge funds shine
-
-
-
BUSINESS3 days ago
Essential Strategies for Startup Bootstrapping and Financial Management
-